Expression of Two Testis-specific Genes, SPATA19 and LEMD1, in Prostate Cancer

Archives of Medical Research

Volumn 41, Issue 3, 2010, Pages 195-200

  Ghafouri Fard, Soudeh ^a   Ousati Ashtiani, Zahra ^a   Sabah Golian, Bareto ^b   Hasheminasab, Seyyed Mohammad ^a   Modarressi, Mohammad Hossein ^a,c  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Sabah Golian Ultrasound Clinic   (Iran)

^c PASTEUR INSTITUTE OF IRAN   (Iran)

Author keywords

Cancer testis antigen; Immunotherapy; LEMD1; ODF.; Prostate cancer; SPATA19

Indexed keywords

CANCER TESTIS ANTIGEN; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOCLAST DIFFERENTIATION FACTOR 1; OSTEOCLAST DIFFERENTIATION FACTOR 2; OSTEOCLAST DIFFERENTIATION FACTOR 3; OSTEOCLAST DIFFERENTIATION FACTOR 4; PROSTATE SPECIFIC ANTIGEN; PROTEIN LEMD1; PROTEIN SPATA19; UNCLASSIFIED DRUG;

AGED; ARTICLE; CANCER DIAGNOSIS; CANCER RISK; CANCER SCREENING; CLINICAL ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; MALE; NUCLEOTIDE SEQUENCE; ORGAN WEIGHT; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROTEIN EXPRESSION; PROTEIN FUNCTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

AGED; AGED, 80 AND OVER; BASE SEQUENCE; CASE-CONTROL STUDIES; DNA PRIMERS; GENE EXPRESSION; HEAT-SHOCK PROTEINS; HUMANS; IMMUNOTHERAPY, ACTIVE; MALE; MIDDLE AGED; MITOCHONDRIAL PROTEINS; NEOPLASM PROTEINS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; SEMINAL PLASMA PROTEINS; TUMOR MARKERS, BIOLOGICAL;

EID: 77953493786     PISSN: 01884409     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcmed.2010.04.003     Document Type: Article

References (26)

1. Kopper L., Timar J. Genomics of prostate cancer: is there anything to " translate" ?. Pathol Oncol Res 2005, 11:197-203.
2. Said J. Biomarker discovery in urogenital cancer. Biomarkers 2005, 10:83-86.
3. Ousati Ashtiani Z., Ayati M., Modarresi M.H., et al. Association of TGIFLX/Y mRNA expression with prostate cancer. Med Oncol 2009, 26:73-77.
4. Old L.J. Cancer immunology: the search for specificity G.H.A. Clowes Memorial Lecture. Cancer Res 1981, 41:361-375.
5. Boon T., Old L.J. Cancer tumor antigens. Curr Opin Immunol 1997, 9:681-683.
6. Simpson A.J.C., Caballero O.L., Jungbluth A., et al. Cancer/testis antigens, gametogenesis and cancer. Nature Rev/Cancer 2005, 5:615-625.
7. Meklat F., Li Z., Wang Z., et al. Cancer-testis antigens in haematological malignancies. Br J Haematol 2007, 136:769-776.
8. Ghafouri-Fard S., Modarressi M.H. Cancer-testis antigens: potential targets for cancer immunotherapy. Arch Iran Med 2009, 12:395-404.
9. Dave D.S., Leppert J.T., Rajfer J. Is the testis a chemo-privileged site? Is there a blood-testis barrier?. Rev Urol 2007, 9:28-32.
10. Parmigiani R.B., Bettoni F., Grosso D.M., et al. Antibodies against the cancer-testis antigen CTSP-1 are frequently found in prostate cancer patients and are an independent prognostic factor for biochemical recurrence. Int J Cancer 2008, 122:2385-2390.
11. Yokokawa J., Bera T.K., Palena C., et al. Identification of cytotoxic T-lymphocyte epitope(s) and its agonist epitope(s) of a novel target for vaccine therapy (PAGE4). Int J Cancer 2007, 121:595-605.
12. Mobasheri M.B., Jahanzad I., Mohagheghi M.A., et al. Expression of two testis-specific genes, TSGA10 and SYCP3, in different cancers regarding their pathological features. Cancer Detect Prev 2007, 31:296-302.
13. Mobasheri M.B., Modarressi M.H., Shabani M., et al. Expression of the testis-specific gene, TSGA10, in Iranian patients with acute lymphoblastic leukemia (ALL). Leuk Res 2006, 30:883-889.
14. Ghafouri-Fard S., Abbasi A., Moslehi H., et al. Elevated expression levels of testis-specific genes TEX101 and SPATA19 in basal cell carcinoma and their correlation with clinical and pathological features. Br J Dermatol 2009, [Epub ahead of print].
15. Kierszenbaum A.L. Keratins: unraveling the coordinated construction of scaffolds in spermatogenic cells. Mol Reprod Dev 2002, 61:1-2.
16. Miyamoto T., Sengoku K., Hayashi H., et al. Isolation and expression analysis of the testis-specific gene, human OPPO1. J Assist Reprod Genet 2004, 21:129-134.
17. Kitamura K., Miyagawa Y., Iguchi N., et al. Molecular cloning and characterization of the human orthologue of the oppo 1 gene encoding a sperm tail protein. Mol Hum Reprod 2003, 9:237-243.
18. Fawcett D.W. The mammalian spermatozoon. Dev Biol 1975, 44:394-436.
19. Baltz J.M., Williams P.O., Cone R.A. Dense fibers protect mammalian sperm against damage. Biol Reprod 1990, 43:485-491.
20. URL: Retrieved February 2010. http://www.genecards.org.
21. Miyamoto T., Sengoku K., Hasuike S., et al. Isolation and expression analysis of the human testis-specific gene, SPERGEN-1, a spermatogenic cell-specific gene-1. J Assist Reprod Genet 2003, 20:101-104.
22. Doiguchi M., Mori T., Toshimori K., et al. Spergen-1 might be an adhesive molecule associated with mitochondria in the middle piece of spermatozoa. Dev Biol 2002, 252:127-137.
23. Yuki D., Lin Y.M., Fuji Y., et al. Isolation of LEM domain-containing 1, a novel testis-specific gene expressed in colorectal cancers. Oncol Rep 2004, 12:275-280.
24. Pachter J.S., de Vries H.E., Fabry Z. The blood-brain barrier and its role in immune privilege in the central nervous system. J Neuropathol Exp Neurol 2003, 62:593-604.
25. Donkor F.F., Mönnich M., Czirr E., et al. Outer dense fibre protein 2 (ODF2) is a self-interacting centrosomal protein with affinity for microtubules. J Cell Sci 2004, 117:4643-4651.
26. Gogvadze V., Orrenius S., Zhivotovsky B. Mitochondria in cancer cells: what is so special about them?. Trends Cell Biol 2008, 18:165-173.